3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
53
Breast Neoplasms
13
Polycystic Ovary Syndrome
8
Infertility
6
Ovarian Hyperstimulation Syndrome
3
Neoplasms
3
Lymphoma
3
Sarcoma, Ewing
2
Sarcoma
2
Prostate Adenocarcinoma
2
Osteosarcoma
2
Uterine Anomalies
1
The Neoadjuvant Therapy
1
Sleep Wake Disorders
1
Salpingitis
1
Salivary Gland Neoplasms
1
Primary Ovarian Insufficiency
1
Pregnancy, Ectopic
1
Neoplasm Metastasis
1
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
1
Myofibroma
1
Metabolic Syndrome
1
Leiomyoma
1
Infertility, Female
1
Hypogonadism
1
Hodgkin Disease
1
Hematopoietic and Lymphatic System Neoplasm
1
Helping Behavior
1
Fatty Liver
1
Fatigue
1
Interventions
telapristone acetate
18
ulipristal acetate
17
Uterine Myomectomy
13
vilaprisan
12
Leuprolide
11
relugolix
9
estradiol, norethindrone drug combination
9
asoprisnil
9
elagolix
7
Uterine Artery Embolization
7
Mifepristone
7
Estradiol
7
Bupivacaine
7
ulipristal
6
Tranexamic Acid
6
Saline Solution
5
Norethindrone Acetate
5
linzagolix
4
epigallocatechin gallate
4
Sodium Chloride
4
Letrozole
4
Hysterectomy
4
Vitamin B 6
3
Sugars
3
Misoprostol
3
Lidocaine
3
Gonadotropin-Releasing Hormone
3
Embolization, Therapeutic
3
cetrorelix
2
Vitamin D
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Leiomyoma
×
Triptorelin Pamoate
×
Clear all
NCT04071574
2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2
Completed
200 enrolled